Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
Eur J Health Econ. 2024 Feb;25(1):103-115. doi: 10.1007/s10198-023-01574-x. Epub 2023 Feb 21.
Eur J Health Econ. 2024.
PMID: 36809586
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
Zhang Y, Ye Y, Tang X, Wang H, Tanaka T, Tian R, Yang X, Wang L, Xiao Y, Hu X, Jin Y, Pang H, Du T, Liu H, Sun L, Xiao S, Dong R, Ferrucci L, Tian Z, Zhang S.
Zhang Y, et al.
J Exp Med. 2022 Aug 1;219(8):e20200418. doi: 10.1084/jem.20200418. Epub 2022 Jun 10.
J Exp Med. 2022.
PMID: 35687056
Free PMC article.
Item in Clipboard
Cite
Cite